These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 3017021

  • 1. [Comparative studies of calcium resorption modified by vitamin D2 and D3 in patients with chronic renal failure and dialysis patients].
    Fünfstück R, Günther K, Tietz U, Brandstädt A, Stein G, Hartwich R.
    Z Urol Nephrol; 1986 Apr; 79(5):287-94. PubMed ID: 3017021
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].
    Hesch RD, Gerlach W, Henning HV, Emrich D, Scheler F, Kattermann R.
    Dtsch Med Wochenschr; 1972 Nov 10; 97(45):1735-8 passim. PubMed ID: 4343379
    [No Abstract] [Full Text] [Related]

  • 4. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D, Byham-Gray L, Lewis E, McCaffrey S.
    J Ren Nutr; 2008 Jul 10; 18(4):375-82. PubMed ID: 18558303
    [Abstract] [Full Text] [Related]

  • 5. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P, Kiely PD.
    Scand J Rheumatol; 2009 Jul 10; 38(2):149-53. PubMed ID: 18991184
    [Abstract] [Full Text] [Related]

  • 6. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL, Hristova M, Ho LT, Sprague SM.
    Am J Nephrol; 2007 Jul 10; 27(1):36-43. PubMed ID: 17215573
    [Abstract] [Full Text] [Related]

  • 7. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women.
    Tjellesen L, Hummer L, Christiansen C, Rødbro P.
    Bone Miner; 1986 Oct 10; 1(5):407-13. PubMed ID: 2849489
    [Abstract] [Full Text] [Related]

  • 8. Renal bone disorders in children: therapy with vitamin D3 or 1,25-dihydroxycholecalciferol.
    Bulla M, Delling G, Offermann G, Ziegler R, Benz G, Lühmann H, Sanchez de Reutter A, Severin M.
    Proc Eur Dial Transplant Assoc; 1979 Oct 10; 16():644-8. PubMed ID: 232917
    [Abstract] [Full Text] [Related]

  • 9. [Comparative antirachitic activity of vitamins D2 and D3 in the body of chicks].
    Valinietse MIu, Bauman VK.
    Prikl Biokhim Mikrobiol; 1981 Oct 10; 17(5):712-9. PubMed ID: 6272266
    [Abstract] [Full Text] [Related]

  • 10. Long-term administration of vitamin D steroles in incipient and advanced renal failure: effect on bone histology.
    Malluche HH, Ritz E, Werner E, Meyer-Sabellek WA.
    Clin Nephrol; 1978 Dec 10; 10(6):219-28. PubMed ID: 215365
    [Abstract] [Full Text] [Related]

  • 11. Serum 24,25-dihydroxyvitamin D3 response to native vitamin D2 and D3 Supplementation in patients with chronic kidney disease on hemodialysis.
    Graeff-Armas LA, Kaufmann M, Lyden E, Jones G.
    Clin Nutr; 2018 Jun 10; 37(3):1041-1045. PubMed ID: 28506446
    [Abstract] [Full Text] [Related]

  • 12. [Vitamin D deficiency and its correction in children with terminal stage of chronic kidney failure].
    Tsybysheva AK, Burkov IV, Blazhevich NV, Pereverzeva OG, Spirichev VB.
    Vopr Med Khim; 1988 Jun 10; 34(4):112-7. PubMed ID: 3264096
    [Abstract] [Full Text] [Related]

  • 13. Model for skeletal resistance to vitamin D in renal failure.
    Weisbrode SE, Capen CC.
    Fed Proc; 1976 Apr 10; 35(5):1225-31. PubMed ID: 177317
    [Abstract] [Full Text] [Related]

  • 14. [Prophylactic treatment of epileptic patients with vitamin D2 and D3. Results of a comparative study of 86 patients (author's transl)].
    Krause KH, Bohn T, Schmidt-Gayk H, Prager P, Ritz E.
    Nervenarzt; 1978 Mar 10; 49(3):174-80. PubMed ID: 205811
    [No Abstract] [Full Text] [Related]

  • 15. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.
    Tokmak F, Quack I, Schieren G, Sellin L, Rattensperger D, Holland-Letz T, Weiner SM, Rump LC.
    Nephrol Dial Transplant; 2008 Dec 10; 23(12):4016-20. PubMed ID: 18593741
    [Abstract] [Full Text] [Related]

  • 16. [Vitamine D in patients with osteoporosis: sufficient or necessary?].
    Ferrari S.
    Rev Med Suisse; 2007 Jun 13; 3(115):1515-6, 1518-20. PubMed ID: 17682795
    [Abstract] [Full Text] [Related]

  • 17. Why dialysis patients need combination therapy with both cholecalciferol and a calcitriol analogs.
    Jones G.
    Semin Dial; 2010 Jun 13; 23(3):239-43. PubMed ID: 20492584
    [Abstract] [Full Text] [Related]

  • 18. Treatment with high-dose oral vitamin D2 in patients with jejunoileal bypass for morbid obesity. Effects on calcium and magnesium metabolism, vitamin D metabolites, and faecal lag time.
    Charles P, Mosekilde L, Søndergård K, Jensen FT.
    Scand J Gastroenterol; 1984 Nov 13; 19(8):1031-8. PubMed ID: 6335925
    [Abstract] [Full Text] [Related]

  • 19. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC, Lin SH, Yu FC, Chyr SH, Shieh SD.
    Miner Electrolyte Metab; 1995 Nov 13; 21(6):398-402. PubMed ID: 8592483
    [Abstract] [Full Text] [Related]

  • 20. [Diagnosis of vitamin B12 deficiency in chronic kidney insufficiency].
    Sperschneider H, Stein G, Lauterbach K, Günther K.
    Z Urol Nephrol; 1984 May 13; 77(5):301-9. PubMed ID: 6475331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.